Physician

Laura Beth Rosenzweig, M.D.

According to 2025 Medicare claims, Laura Rosenzweig, M.D. (NPI: 1689857427) practices micrographic dermatologic surgery in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Mecklenburg, NC. This provider's primary affiliated billing organization is PIEDMONT PLASTIC SURGERY & DERMATOLOGY PA (NPI: 1801832837; TIN: 561881165) and primary practice location at 28277-5732.

Rosenzweig's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,059 traditional Medicare patients, billed 4,899 HCPCS/CPT codes, and received $648,166 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 583 prescription claims across 337 beneficiaries totaling $245,647 in drug costs, led by Erivedge (Vismodegib). Open Payments data shows 43 records totaling $988. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $17,478 to $245,647. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	743	3,189	$454,332
2016	740	3,024	$421,977
2017	828	3,503	$481,862
2018	933	4,783	$522,050
2019	1,056	5,010	$583,794
2020	971	4,321	$529,484
2021	976	4,784	$569,410
2022	1,001	4,155	$544,204
2023	983	4,560	$578,076
2024	1,059	4,899	$648,166

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	209	425	$17,478
2016	194	320	$11,514
2017	202	370	$70,696
2018	263	491	$178,805
2019	309	580	$145,503
2020	294	549	$115,758
2021	293	579	$515,205
2022	277	481	$202,545
2023	335	568	$234,497
2024	337	583	$245,647

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	420	519	$480
11102	Biopsy of related skin growth, first growth	191	238	$62
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	488	629	$58
17000	Destruction of precancer skin growth, 1 growth	286	368	$37
17003	Destruction of precancer skin growth, 2-14 growths	197	1,061	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erivedge	Vismodegib	35	1,026	$170,680
Fluorouracil	Fluorouracil	24	640	$1,520
Mupirocin	Mupirocin	98	1,979	$759
Clobetasol Propionate	Clobetasol Propionate	20	480	$660
Doxycycline Hyclate	Doxycycline Hyclate	59	768	$523

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	43	$988	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Laura Beth Rosenzweig, M.D.?

Tedicare shows public-source Medicare data for Laura Beth Rosenzweig, M.D. (NPI 1689857427), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Laura Beth Rosenzweig, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Laura Beth Rosenzweig, M.D.?

Laura Beth Rosenzweig, M.D. is linked to PIEDMONT PLASTIC SURGERY & DERMATOLOGY PA (billing NPI 1801832837) in the available physician profile data.

Does Laura Beth Rosenzweig, M.D. have Open Payments data?

Laura Beth Rosenzweig, M.D. has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.